Critical Insights From Hologic Analyst Ratings: What You Need To Know
Needham Maintains Hologic(HOLX.US) With Buy Rating, Maintains Target Price $90
Hologic Analyst Ratings
Needham Reiterates Buy on Hologic, Maintains $90 Price Target
Hologic: A Buy Rating Amidst Temporary Challenges and Growth Potential
Nephron Trims Price Target on Hologic to $92 From $95
Citi Maintains Hologic(HOLX.US) With Buy Rating, Maintains Target Price $95
Citi Remains a Buy on Hologic (HOLX)
Hologic Price Target Maintained With a $82.00/Share by RBC Capital
Hologic Analyst Ratings
RBC Capital Maintains Hologic(HOLX.US) With Hold Rating, Maintains Target Price $82
RBC Capital Sticks to Their Hold Rating for Hologic (HOLX)
Stephens Raises Hologic's Price Target to $95 From $92
Morgan Stanley Maintains Hologic(HOLX.US) With Hold Rating, Maintains Target Price $84
Morgan Stanley Sticks to Its Hold Rating for Hologic (HOLX)
BofA Securities Initiates Hologic(HOLX.US) With Hold Rating, Announces Target Price $82
Hologic: Hold Rating Maintained Amid Solid Q3 Performance and Revised Full Year Guidance
BNP Paribas Exane Adjusts Price Target on Hologic to $96 From $95
Hologic Price Target Raised to $82.00/Share From $81.00 by RBC Capital
RBC Capital Maintains Sector Perform on Hologic, Raises Price Target to $82